Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

BLTE — BELITE BIO, INC SEC Filings | FilingIndex

BLTENasdaq

BELITE BIO, INC

Pharmaceutical Preparations · E9 · CIK 1889109

BELITE BIO, INC develops and commercializes novel therapeutics for rare genetic diseases

+ Watch View on EDGAR ↗

$5.54B

Market cap

$153.99

Last close

-0.4%

1D

+6.1%

5D

225K

Volume

Price · last 40 sessions-0.3%

May 4L $134.93 · H $156.21Jun 30

69

Total filings

Jun 15, 2026

Last filing

12/31

Fiscal year end

All 6-K · 52 424B5 · 8 20-F · 4 SC 13G · 4 424B4 · 1

SC 13GSC 13GFeb 12, 2024 SC 13GSC 13GFeb 12, 2024 SC 13GSC 13GFeb 15, 2023 SC 13GSC 13GFeb 14, 2023

Similar companies

Comparable business profile · signals at a glance

VIRVir Biotechnology, Inc.$1.5B-1.8%ANLAdlai Nortye Ltd.$664.6M+0.8%ACRSAclaris Therapeutics, Inc.$603.3M+5.4%SLGLSol-Gel Technologies Ltd.$240.1M-0.4%RCUSArcus Biosciences, Inc.

$3.0B

-0.8%

ACIUAC Immune SA$235.1M-10.5%